Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach

International Journal of Cardiovascular Imaging

Volumn 28, Issue 6, 2012, Pages 1329-1339

  Aboukhoudir, Falah ^a   Rekik, Sofiene ^a,b  

^a Avignon Hospital Center   (France)

^b Antibes Hospital Center   (France)

Author keywords

Diabetes mellitus; Dobutamine stress echocardiography; Left ventricular ejection fraction

Indexed keywords

DOBUTAMINE; GLYCOSYLATED HEMOGLOBIN; PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DETERIORATION; DIABETIC CARDIOMYOPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; DYSPNEA; FEMALE; GLYCEMIC CONTROL; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROCESS OPTIMIZATION; PROTEINURIA; SMOKE; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VASOSPASM;

ADRENERGIC AGONISTS; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84870437508     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9938-7     Document Type: Article

References (23)

1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431 (Pubitemid 28405191)
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (United Kingdom Prospective Diabetes Study 35): prospective observational study. BMJ 321:405-412 (Pubitemid 30609442)
3. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC (2000) Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35:1628-1637 (Pubitemid 30307510)
4. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigorito C, Saccà L, Toffolo G, Cobelli C, Trevisan R (1990) Myocardial metabolism in insulin deficient diabetic humans without coronary artery disease. Am J Physiol 258:E606-E618 (Pubitemid 20142341)
5. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595-602
6. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121(9):748-757
7. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I (1989) Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367
8. Poldermans D, Fioretti PM, Boersma E, Bax JJ, Thomson IR, Roelandt JR, Simoons ML (1999) Long-term prognostic value of dobutamine-atropine stress echocardiography in 1, 737 patients with known or suspected coronary artery disease: a single-center experience. Circulation; 99:757-762 (Pubitemid 29083015)
9. Aboukhoudir F, Rekik S, Andrieu S, Cheggour S, Pansieri M, Metge M, Barnay P, Faugier JP, Schouvey S, Quaino G, Unal C, Gonzalez S, Hirsch JL (2009) Coronary artery spasm and dobutamine stress echocardiography. Eur J Echocardiogr 10(4):556-561
10. Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11(1):31-39
11. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive diabetic mellitus. Am J Cardiol 93:870-875 (Pubitemid 38429599)
12. Andersen NH, Poulsen SH, Eiskjaer H, Poulsen PL, Mogensen CE (2003) Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study. Clin Sci (Lond) 105:59-66 (Pubitemid 36819577)
13. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH (2005) Screening for heart disease in diabetic subjects. Am Heart J 149(2):349-354 (Pubitemid 40348547)
14. Palmieri V, Capaldo B, Russo C, Iaccarino M, Pezzullo S, Quintavalle G, Di Minno G, Riccardi G, Celentano A (2008) Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: Insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res Clin Pract 79(2):262-268
15. Ha JW, Lee HC, Kang ES, Ahn CM, Kim JM, Ahn JA, Lee SW, Choi EY, Rim SJ, Oh JK, Chung N (2007) Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart 93:1571-1576 (Pubitemid 350205552)
16. Fang ZY, Najos-Valencia O, Leano R, Marwick TH (2003) Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol 42:446-453 (Pubitemid 36951709)
17. Scognamiglio R, Avogaro A, Casara D, Crepaldi C, Marin M, Palisi M, Mingardi R, Erle G, Fasoli G, Dalla Volta S (1998) Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31:404-412 (Pubitemid 28153462)
18. Von Bibra H, Thrainsdottir IS, Hansen A et al (2005) Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2:24-30 (Pubitemid 40333201)
19. Von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Ryde'n L (2004) Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 90:1483-1484 (Pubitemid 39626336)
20. Konduracka E, Gackowski A, Rostoff P, Galicka-Latala D, Frasik W, Piwowarska W (2007) Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. Eur Heart J 28:2465-2471 (Pubitemid 47614285)
21. Zaman AK, Fujii S, Goto D, Furumoto T, Mishima T, Nakai Y, Dong J, Imagawa S, Sobel BE, Kitabatake A (2004) Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. J Mol Cell Cardiol 37:525-535 (Pubitemid 38953380)
22. Kawasaki D, Kosugi K, Waki H, Yamamoto K, Tsujino T, Masuyama T (2007) Role of activated renin angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients-reversal by chronic angiotensin II type 1A receptor blockade. Circ J 71:524-529 (Pubitemid 46513459)
23. Patel A, ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 8(370):829-840 (Pubitemid 47362321)